Cardiology Activities
Managing Preserved and Reduced Ejection Fraction in Heart Failure: An Evidence-Based Case Review
0290-0000-20-313-L01-P
This live activity will identify current treatment and management of HFpEF and challenges faced in HFpEF treatment.
12-08-2020
1.50
Implementing Effective Protocols When Using Direct Oral Anticoagulant Reversal Agents: A Review of Updated Guidelines and Clinical Data
0290-0000-20-271-H01-P
This article will analyze the mechanisms of action, safety and efficacy data, and adverse effects associated with the use of approved DOAC reversal agents.
2.00
Chronic CAD and PAD: Reducing Major Adverse Cardiovascular Events With Dual Pathway Inhibition Antithrombotic Therapy
0290-0000-20-281-H01-P
This activity will review guidelines for treatment of secondary prevention of CAD and PAD, as well as identification of when to recommend antithrombotic therapy, and counseling points pharmacists can provide to patients regarding lifestyle modifications for prevention of CAD and PAD.
2.00
A Pharmacist's Perspective in Hyperkalemia: Improving Clinical Outcomes With Safe and Effective Treatment Options
0290-0000-20-209-H01-P
This activity will review appropriate use, efficacy, and safety of treatments for hyperkalemia so pharmacists can ensure patients are receiving the appropriate therapy at the right time to provide optimal care.
0.75